The CCAAT enhancer-binding protein-α negatively regulates the transactivation of androgen receptor in prostate cancer cells

Molecular Endocrinology

Volumn 20, Issue 5, 2006, Pages 984-995

  Chattopadhyay, Soma ^a   Gong, Eun Yeung ^a   Hwang, Miok ^a   Park, Eunsook ^a   Hyun, Joo Lee ^a   Cheol, Yi Hong ^a   Choi, Hueng Sik ^a   Cheong, Jae Hun ^b   Hyuk, Bang Kwon ^a   Lee, Keesook ^a  

^a Chonnam National University   (South Korea)

^b Pusan National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; CCAAT ENHANCER BINDING PROTEIN ALPHA; PROSTATE SPECIFIC ANTIGEN; REPRESSOR PROTEIN;

ANIMAL; ARTICLE; CELL PROLIFERATION; CHEMISTRY; DOWN REGULATION; DRUG ANTAGONISM; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; MALE; METABOLISM; PROMOTER REGION; PROSTATE; PROSTATE TUMOR; RAT; TRANSACTIVATION; TUMOR CELL LINE;

ANIMALS; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; PROMOTER REGIONS (GENETICS); PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RATS; RECEPTORS, ANDROGEN; REPRESSOR PROTEINS; TRANS-ACTIVATION (GENETICS);

EID: 33746576757     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2005-0240     Document Type: Article

References (52)

1. Gelmann EP 2002 Molecular biology of the androgen receptor. J Clin Oncol 20:3001-3015
2. Cunha GR, Donjacour AA, Cooke PS, Mee S, Bigsby RM, Higgins SJ, Sugimura Y 1987 The endocrinology and developmental biology of the prostate. Endocr Rev 8:338-362
3. Davies P, Eaton CL 1991 Regulation of prostate growth. J Endocrinol 131:5-17
4. Fujimoto N, Mizokami A, Harada S, Matsumoto T 2001 Different expression of androgen receptor coactivators in human prostate. Urology 58:289-294
5. Marker PC, Donjacour AA, Dahiya R, Cunha GR 2003 Hormonal, cellular, and molecular control of prostatic development. Dev Biol 253:165-174
6. Tsai MJ, O'Malley BW 1994 Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem 63:451-486
7. Langley E, Zhou ZX, Wilson EM 1995 Evidence for an anti-parallel orientation of the ligand-activated human androgen receptor dimer. J Biol Chem 270:29983-29990
8. Wong CI, Zhou ZX, Sar M, Wilson EM 1993 Steroid requirement for androgen receptor dimerization and DNA binding. Modulation by intramolecular interactions between the NH2-terminal and steroid-binding domains. J Biol Chem 268:19004-19012
9. Truss M, Bartsch J, Schelbert A, Hache RJ, Beato M 1995 Hormone induces binding of receptors and transcription factors to a rearranged nucleosome on the MMTV promoter in vivo. EMBO J 14:1737-1751
10. Bannister AJ, Kouzarides T 1996 The CBP co-activator is a histone acetyltransferase. Nature 384:641-643
11. Ogryzko VV, Schiltz RL, Russanova V, Howard BH, Nakatani Y 1996 The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87:953-959
12. Imhof A, Yang XJ, Ogryzko VV, Nakatani Y, Wolffe AP, Ge H 1997 Acetylation of general transcription factors by histone acetyltransferases. Curr Biol 7:689-692
13. Nagy L, Kao HY, Chakravarti D, Lin RJ, Hassig CA, Ayer DE, Schreiber SL, Evans RM 1997 Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. Cell 89:373-380
14. Dedhar S, Rennie PS, Shago M, Hagesteijn CY, Yang H, Filmus J, Hawley RG, Bruchovsky N, Cheng H, Matusik RJ, Giguere V 1994 Inhibition of nuclear hormone receptor activity by calreticulin. Nature 367:480-483
15. Umek RM, Friedman AD, McKnight SL 1991 CCAAT-enhancer binding protein: a component of a differentiation switch. Science 251:288-292
16. Timchenko NA, Wilde M, Darlington GJ 1999 C/EBPα regulates formation of S-phase-specific E2F-p107 complexes in livers of newborn mice. Mol Cell Biol 19: 2936-2945
17. Soriano HE, Kang DC, Finegold MJ, Hicks MJ, Wang ND, Harrison W, Darlington GJ 1998 Lack of C/EBP α gene expression results in increased DNA synthesis and an increased frequency of immortalization of freshly isolated mice [correction of rat] hepatocytes. Hepatology [Erratum (1998) 27:1457] 27:392-401
18. Wang H, Iakova P, Wilde M, Welm A, Goode T, Roesler WJ, Timchenko NA 2001 C/EBPα arrests cell proliferation through direct inhibition of Cdk2 and Cdk4. Mol Cell 8:817-828
19. Iakova P, Awad SS, Timchenko NA 2003 Aging reduces proliferative capacities of liver by switching pathways of C/EBPα growth arrest. Cell 113:495-506
20. Porse BT, Pedersen TA, Xu X, Lindberg B, Wewer UM, Friis-Hansen L, Nerlov C 2001 E2F repression by C/EBPα is required for adipogenesis and granulopoiesis in vivo. Cell 107:247-258
21. Keeshan K, Santilli G, Corradini F, Perrotti D, Calabretta B 2003 Transcription activation function of C/EBPα is required for induction of granulocytic differentiation. Blood 102:1267-1275
22. Wang QF, Cleaves R, Kummalue T, Nerlov C, Friedman AD 2003 Cell cycle inhibition mediated by the outer surface of the C/EBPα basic region is required but not sufficient for granulopoiesis. Oncogene 22:2548-2557
23. Birkenmeier EH, Gwynn B, Howard S, Jerry J, Gordon JI, Landschulz WH, McKnight SL 1989 Tissue-specific expression, developmental regulation, and genetic mapping of the gene encoding CCAAT/enhancer binding protein. Genes Dev 3:1146-1156
24. Cao Z, Umek RM, McKnight SL 1991 Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev 5:1538-1552
25. Scott LM, Civin CI, Rorth P, Friedman AD 1992 A novel temporal expression pattern of three C/EBP family members in differentiating myelomonocytic cells. Blood 80:1725-1735
26. Maytin EV, Habener JF 1998 Transcription factors C/EBP α, C/EBP β, and CHOP (Gadd153) expressed during the differentiation program of keratinocytes in vitro and in vivo. J Invest Dermatol 110:238-246
27. Chandrasekaran C, Gordon JI 1993 Cell lineage-specific and differentiation-dependent patterns of CCAAT/enhancer binding protein α expression in the gut epithelium of normal and transgenic mice. Proc Natl Acad Sci USA 90:8871-8875
28. Frohling S, Schlenk RF, Stolze I, Bihlmayr J, Benner A, Kreitmeier S, Tobis K, Dohner H, Dohner K 2004 CEBPA mutations in younger adults with acute myeloid leukemia and normal cytogenetics: prognostic relevance and analysis of cooperating mutations. J Clin Oncol 22:624-633
29. Antonson P, Xanthopoulos KG 1995 Molecular cloning, sequence, and expression patterns of the human gene encoding CCAAT/enhancer binding protein α (C/EBP α). Biochem Biophys Res Commun 215:106-113
30. Weihua Z, Lathe R, Warner M, Gustafsson JA 2002 An endocrine pathway in the prostate, ERβ, AR, 5α-androstane-3β,17β-diol, and CYP7B1, regulates prostate growth. Proc Natl Acad Sci USA 99:13589-13594
31. Brothman AR, Lesho LJ, Somers KD, Schellhammer PF, Ladaga LE, Merchant DJ 1989 Cytogenetic analysis of four primary prostatic cultures. Cancer Genet Cytogenet 37:241-248
32. Pabst T, Mueller BU, Zhang P, Radomska HS, Narravula S, Schnittger S, Behre G, Hiddemann W, Tenen DG 2001 Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-α (C/EBPα), in acute myeloid leukemia. Nat Genet 27:263-270
33. Jin B, Turner L, Walters WA, Handelsman DJ 1996 The effects of chronic high dose androgen or estrogen treatment on the human prostate [corrected]. J Clin Endocrinol Metab [Erratum (1997) 82:413] 81:4290-4295
34. Ossipow V, Descombes P, Schibler U 1993 CCAAT/ enhancer-binding protein mRNA is translated into multiple proteins with different transcription activation potentials. Proc Natl Acad Sci USA 90:8219-8223
35. Holter E, Kotaja N, Makela S, Strauss L, Kietz S, Janne OA, Gustafsson JA, Palvimo JJ, Treuter E 2002 Inhibition of androgen receptor (AR) function by the reproductive orphan nuclear receptor DAX-1. Mol Endocrinol 16:515-528
36. Berrevoets CA, Doesburg P, Steketee K, Trapman J, Brinkmann AO 1998 Functional interactions of the AF-2 activation domain core region of the human androgen receptor with the amino-terminal domain and with the transcriptional coactivator TIF2 (transcriptional intermediary factor2). Mol Endocrinol 12:1172-1183
37. Hong H, Kohli K, Trivedi A, Johnson DL, Stallcup MR 1996 GRIP1, a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domains of steroid receptors. Proc Natl Acad Sci USA 93:4948-4952
38. Voegel JJ, Heine MJ, Zechel C, Chambon P, Gronemeyer H 1996 TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO J 15:3667-3675
39. Bevan CL, Hoare S, Claessens F, Heery DM, Parker MG 1999 The AF1 and AF2 domains of the androgen receptor interact with distinct regions of SRC1. Mol Cell Biol 19:8383-8392
40. He B, Bowen NT, Minges JT, Wilson EM 2001 Androgen-induced NH2- and COOH-terminal interaction inhibits p160 coactivator recruitment by activation function 2. J Biol Chem 276:42293-42301
41. Slomiany BA, D'Arigo KL, Kelly MM, Kurtz DT 2000 C/EBPα inhibits cell growth via direct repression of E2F-DP-mediated transcription. Mol Cell Biol 20:5986-5997
42. Gombart AF, Hofmann WK, Kawano S, Takeuchi S, Krug U, Kwok SH, Larsen RJ, Asou H, Miller CW, Hoelzer D, Koeffler HP 2002 Mutations in the gene encoding the transcription factor CCAAT/enhancer binding protein α in myelodysplastic syndromes and acute myeloid leukemias. Blood 99:1332-1340
43. Singh R, Artaza JN, Taylor WE, Gonzalez-Cadavid NF, Bhasin S 2003 Androgens stimulate myogenic differentiation and inhibit adipogenesis in C3H 10T1/2 pluripotent cells through an androgen receptor-mediated pathway. Endocrinology 144:5081-5088
44. Jeong BC, Hong CY, Chattopadhyay S, Park JH, Gong EY, Kim HJ, Chun SY, Lee K 2004 Androgen receptor corepressor-19 kDa (ARR19), a leucine-rich protein that represses the transcriptional activity of androgen receptor through recruitment of histone deacetylase. Mol Endocrinol 18:13-25
45. Shang Y, Myers M, Brown M 2002 Formation of the androgen receptor transcription complex. Mol Cell 9:601-610
46. Lee YS, Kim HJ, Lee HJ, Lee JW, Chun SY, Ko SK, Lee K 2002 Activating signal cointegrator 1 is highly expressed in murine testicular Leydig cells and enhances the ligand-dependent transactivation of androgen receptor. Biol Reprod 67:1580-1587
47. Chen H, Nandi AK, Li X, Bieberich CJ 2002 NKX-3.1 interacts with prostate-derived Ets factor and regulates the activity of the PSA promoter. Cancer Res 62:338-340
48. Hong SH, Lee MY, Cheong JH 2001 Functional interaction of transcriptional coactivator ASC-2 and C/EBPα in granulocyte differentiation of HL-60 promyelocytic cell. Biochem Biophys Res Commun 282:1257-1262
49. Hong CY, Park JH, Ahn RS, Im SY, Choi HS, Soh J, Mellon SH, Lee K 2004 Molecular mechanism of suppression of testicular steroidogenesis by proinflammatory cytokine tumor necrosis factor α. Mol Cell Biol 24:2593-2604
50. Song KH, Park YY, Park KC, Hong CY, Park JH, Shong M, Lee K, Choi HS 2004 The atypical orphan nuclear receptor DAX-1 interacts with orphan nuclear receptor Nur77 and represses its transactivation. Mol Endocrinol 18:1929-1940
51. Heckman CA, Wheeler MA, Boxer LM 2003 Regulation of Bcl-2 expression by C/EBP in t(14;18) lymphoma cells. Oncogene 22:7891-7899
52. Qiao L, Maclean PS, Schaack J, Orlicky DJ, Darimont C, Pagliassotti M, Friedman JE, Shao J 2005 C/EBPα regulates human adiponectin gene transcription through an intronic enhancer. Diabetes 54:1744-1754